Eur Rev Med Pharmacol Sci 2021; 25 (5): 2166-2167

DOI: 10.26355/eurrev_202103_25205

Hyperlipidemia management during the COVID-19 pandemic: PCSK9 inhibitors to enhance the antiviral action of interferon

M. Leggio, A. Villano, A. Fusco, A. Mazza

Clinical and Rehabilitative Cardiology Unit, San Filippo Neri Hospital, ASL Roma 1, Rome, Italy. mleggio@libero.it


Free PDF Download

To cite this article

M. Leggio, A. Villano, A. Fusco, A. Mazza
Hyperlipidemia management during the COVID-19 pandemic: PCSK9 inhibitors to enhance the antiviral action of interferon

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 5
Pages: 2166-2167
DOI: 10.26355/eurrev_202103_25205